Advanced search
Add to list

Systemic immune epigenomic predictors of immunotherapy response in NSCLC patients : potential and pitfalls

(2025)
Author
Promoter
(UGent) , (UGent) and (UGent)
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Marcos Rubio, Alvaro. Systemic Immune Epigenomic Predictors of Immunotherapy Response in NSCLC Patients : Potential and Pitfalls. Ghent University. Faculty of Medicine and Health Sciences, 2025.
APA
Marcos Rubio, A. (2025). Systemic immune epigenomic predictors of immunotherapy response in NSCLC patients : potential and pitfalls. Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium.
Chicago author-date
Marcos Rubio, Alvaro. 2025. “Systemic Immune Epigenomic Predictors of Immunotherapy Response in NSCLC Patients : Potential and Pitfalls.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
Chicago author-date (all authors)
Marcos Rubio, Alvaro. 2025. “Systemic Immune Epigenomic Predictors of Immunotherapy Response in NSCLC Patients : Potential and Pitfalls.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
Vancouver
1.
Marcos Rubio A. Systemic immune epigenomic predictors of immunotherapy response in NSCLC patients : potential and pitfalls. [Ghent, Belgium]: Ghent University. Faculty of Medicine and Health Sciences; 2025.
IEEE
[1]
A. Marcos Rubio, “Systemic immune epigenomic predictors of immunotherapy response in NSCLC patients : potential and pitfalls,” Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium, 2025.
@phdthesis{01JNED5CE9FB3JC63RG7A69KRG,
  author       = {{Marcos Rubio, Alvaro}},
  language     = {{eng}},
  pages        = {{194}},
  publisher    = {{Ghent University. Faculty of Medicine and Health Sciences}},
  school       = {{Ghent University}},
  title        = {{Systemic immune epigenomic predictors of immunotherapy response in NSCLC patients : potential and pitfalls}},
  year         = {{2025}},
}